GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Agenus Inc. (AGEN) [hlAlert]

Rating:
Outperform
AGEN
up 227.48 %

Agenus Inc. (AGEN) rated Outperform by William Blair

Posted on: Thursday,  Jan 5, 2012  2:25 PM ET by William Blair

William Blair rated Outperform Agenus Inc. (NASDAQ: AGEN) on 01/05/2012, when the stock price was $2.11. Since
then, Agenus Inc. has gained 227.49% as of 01/21/2016's recent price of $6.91.
If you would have followed this William Blair's recommendation on AGEN, you would have gained 227.48% of your investment in 1477 days.

Antigenics Inc. is engaged in the discovery and development of a family of novel immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight disease. The company is evaluating the lead immunotherapeutic, Oncophage, in six separate phase II or phase I/II clinical trials in four different cancers. The company is also developing immunotherapeutics to treat infectious diseases, such as genital herpes, and autoimmune disorders, such as diabetes and multiple sclerosis.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/5/2012 2:25 PM Buy
None
2.11
as of 12/31/2012
1 Week up  7.04 %
1 Month down  -5.31 %
3 Months down  -11.06 %
1 YTD up  94.31 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy